ACR is but a few days away; the question is: how will you tackle this virtual meeting? RheumNow has created several options for learning the way you want to. First is to feed your need. Are you a lupologist? A gout maven? A Spondylitis sleuth? A drug safety wannabe?
The SPIRIT-P1 study has demonstrated the safety and efficacy of ixekizumab (an IL-17A antagonist) when given to adults w/ active psoriatic arthritis (PsA), and also demonstrating radiographic protection and improvement in skin outcomes as well.
Dr. John Cush RheumNow
5 years 11 months ago
Systematic review of the literatures (19 studies, 241 138 participants) shows ibuprofen vs acetaminophen for fever or pain in children <2 years was associated with equivalent safety and improved temperature and pain within the first 24 hours https://t.co/4y5dww22Gw
SPARTAN has compiled a list of presentations and sessions worth seeing if you are interested in ankylosing spondylitis, spondyloarthritis and related disorders.
Dr. John Cush RheumNow
5 years 11 months ago
Study of 55 SpA patients with axial disease. 31% had high risk of falls (by survey) and 25% recalled having at least one fall in the last years. Risk higher w/ activity and adv disease. Pts w/ falls had lower quality of life. https://t.co/yu6mP6sxth
"The US has nearly 4.5% of the world’s population but accounts for more than 40% of global drug spending" reports JAMA Internal Medicine. US drug prices are nearly double those of Australia, Canada, and the United Kingdom, and the US spends twice as much on retail and nonretail drugs per capita as Switzerland, the country with the next highest spending.
QD Clinic- HIV and Joint Pain
Differential Dx of Arthritis in HIV+ individuals
Dr. John Cush RheumNow
5 years 11 months ago
FDA Grants Priority Review and EMA Accepts Regulatory Submission for Pfizer’s Abrocitinib, an Oral Once-Daily JAK1 Inhibitor, for Patients 12 and Up with Moderate to Severe Atopic Dermatitis https://t.co/I2dzetdgBw
Dr. John Cush RheumNow
5 years 11 months ago
Lowest Specialty Salaries in 2020
Preventive med: $234K
Pediatrics: $243K
Medical genetics: $252K
Endocrine: $259K
Family med: $261K
Geriatrics: $272K
Infectious dz: $277K
Internal med: $280K
Rheumatology: $289K
Occupational med: $293K
Rheum! we are #9 https://t.co/zEs8WxVgG9
KenWarringtonMD MdWarrington
5 years 11 months ago
Exciting to hear about 5 trials for #GCA
1. ABAGART (#Abatacept)
2. METOGIA (#tocilizumab vs MTX)
3. SELECT (#upadacitinib)
4. MAVRILIMUMAB (#gmcsf i)
5. TiTIAN (#secukinumab)
@VasculitisFound #vasculitis #vcrc https://t.co/DVvG5Ekfu9
Dr. John Cush RheumNow
5 years 11 months ago
Did you see the results of our "Are Rheums Attending ACR 2020?" Survey.
41% will attend live
23% will learn off hours
2/3 are registered for ACR
20% just won't go
37% are taking time off to attend
See ou recs on how to learn based on where you fit above
https://t.co/K4qHSJ07P2
Dr. John Cush RheumNow
5 years 11 months ago
RheumNow Podcast is UP! ACR 20 is Coming to Town - news on melanoma, COVID biologics & autoantibodies, Hepatitis & JAKs, Safety of nintedinib, upcoming ACR2020. Watch it here> https://t.co/np5aFCo9FB or listen on Apple> https://t.co/FHJv01AAbC or Android> https://t.co/qxuBmiNxU0
Dr. John Cush RheumNow
5 years 11 months ago
This is the best blog I've ever written. https://t.co/u2kHUD4sSw
ACR 2020 (aka ACR Convergence) is just around the corner, with the opening ceremonies and lecture starting Thursday, November 5th; followed by the full meeting beginning the next morning, Friday November 6th.
Dr. John Cush RheumNow
5 years 11 months ago
Wilson’s dz- autosomal recessive w/ incr copper deposition in brain, liver & joints (<50%) w/ premature OA in wrist, MCPs, knees & spine. Dx by LOW serum ceruloplasmin , HIGH urinary copper, hepatic copper levels, or mutations in ATP7B gene https://t.co/CoEpcjRnHt
